BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 207751)

  • 1. Cyclic AMP phosphodiesterase in human lymphocytes and lymphoblasts.
    Takemoto DJ; Lee WN; Kaplan SA; Appleman MM
    J Cyclic Nucleotide Res; 1978 Apr; 4(2):123-32. PubMed ID: 207751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in normal and chronic lymphocytic leukemia lymphocytes.
    Scher NS; Quagliata F; Malathi VG; Faig D; Melton RA; Silber R
    Cancer Res; 1976 Nov; 36(11 Pt 1):3958-62. PubMed ID: 184920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phosphatidylethanolamine methylase and cyclic nucleotide phosphodiesterase activities in human B lymphoid hemopathies].
    Pacheco Y; Magaud JP; Dubois M; French M; Fonlupt P; Prigent AF; Rey C; Germain D; Pacheco H
    C R Acad Sci III; 1985; 301(16):711-6. PubMed ID: 3000540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early increase in lymphocyte cyclic nucleotide phosphodiesterase activity upon mitogenic activation of human peripheral blood mononuclear cells.
    Meskini N; Hosni M; Nemoz G; Lagarde M; Prigent AF
    J Cell Physiol; 1992 Jan; 150(1):140-8. PubMed ID: 1309823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3':5'-cyclic-nucleotide phosphodiesterases of mammalian sera.
    Asano T; Hidaka H
    Biochim Biophys Acta; 1975 Jul; 397(1):124-33. PubMed ID: 238629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic adenosine 3':5'-monophosphate levels and activities of related enzymes in normal and leukemic lymphocytes.
    Monahan TM; Marchand NW; Fritz RR; Abell CW
    Cancer Res; 1975 Sep; 35(9):2540-7. PubMed ID: 167962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
    Azhaeva EV; Severin ES
    Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the cyclic nucleotide phosphodiesterases of normal and leukemic lymphocytes.
    Hait WN; Weiss B
    Biochim Biophys Acta; 1977 Mar; 497(1):86-100. PubMed ID: 14711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of cyclic nucleotide phosphodiesterase from isolated human peripheral blood lymphocytes by mitogenic agents.
    Epstein PM; Mills JS; Hersh EM; Strada SJ; Thompson WJ
    Cancer Res; 1980 Feb; 40(2):379-86. PubMed ID: 6243252
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclic nucleotide phosphodiesterase in normal and leukemic human lymphocytes and lymphoblasts.
    Epstein PM; Hachisu R
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():303-24. PubMed ID: 6202124
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of cyclic GMP-binding and cyclic AMP-specific phosphodiesterases of rat platelets by a mechanism involving cyclic AMP-dependent phosphorylation.
    Tremblay J; Lachance B; Hamet P
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):397-411. PubMed ID: 2411769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
    Hoskins B; Luong HB
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine.
    Thompson WJ; Ross CP; Hersh EM; Epstein PM; Strada SJ
    J Cyclic Nucleotide Res; 1980; 6(1):25-36. PubMed ID: 6155390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
    Hait WN; Weiss B
    Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet cyclic 3':5'-nucleotide phosphodiesterase released by thrombin and calcium ionophore.
    Hidaka H; Asano T
    J Biol Chem; 1976 Dec; 251(23):7508-16. PubMed ID: 187590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
    Rose RJ; Liu H; Palmer D; Maurice DH
    Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
    Hidaka H; Asano T
    Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The seasonal rhythm of changes in adenosine cyclic monophosphate phosphodiesterase activity in the lymphocytes of human peripheral blood].
    Kochetkova MN; Ozeretskovskaia NN; Ezhkova NG
    Izv Akad Nauk SSSR Biol; 1988; (5):782-5. PubMed ID: 2849615
    [No Abstract]   [Full Text] [Related]  

  • 20. Variation of activity of protein kinases in unstimulated and phytohemagglutinin-stimulated normal and leukemic human lymphocytes.
    Carpentieri U; Minguell JJ; Haggard ME
    Cancer Res; 1980 Aug; 40(8 Pt 1):2714-8. PubMed ID: 6248212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.